Work

Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19 – Authors' reply

Year: 2020

Type: letter

Source: The Lancet Rheumatology

DOI: 10.1016/s2665-9913(20)30415-x

Authors: Jonas Bovijn, Cecilia M Lindgren, Michael V Holmes

Institutions: University of Oxford, MRC Population Health Research Unit

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bill and Melinda Gates Foundation, Pfizer, Bayer, Li Ka Shing Foundation, NIHR Bristol Biomedical Research Centre, National Institute for Health and Care Research, British Heart Foundation, Rhodes Scholarships, Deutsche Forschungsgemeinschaft, Novo Nordisk, Clarendon Fund

Awards: G2693665147, SFB 877: Proteolyse als regulatorisches Ereignis in der Pathophysiologie, Drug target validation and risk prediction for coronary heart disease using targeted blood-based metabolomics and proteomics

OpenAlex ID: W3112831058

Cites: 7

Cited by: 6

Related to: 10